Brookstone Capital Management Purchases 10,064 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Brookstone Capital Management boosted its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 2.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 491,831 shares of the real estate investment trust’s stock after purchasing an additional 10,064 shares during the period. Brookstone Capital Management owned about 0.07% of Healthpeak Properties worth $9,969,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. HM Payson & Co. bought a new position in Healthpeak Properties during the 3rd quarter valued at about $25,000. S.A. Mason LLC bought a new position in Healthpeak Properties during the 3rd quarter valued at about $26,000. Rise Advisors LLC bought a new position in Healthpeak Properties during the 3rd quarter valued at about $29,000. Fortitude Family Office LLC bought a new position in Healthpeak Properties during the 3rd quarter valued at about $32,000. Finally, Barrett & Company Inc. bought a new position in Healthpeak Properties during the 3rd quarter valued at about $33,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Stock Up 1.8 %

Shares of NYSE DOC opened at $20.01 on Tuesday. The stock has a market cap of $14.00 billion, a P/E ratio of 42.58, a P/E/G ratio of 2.31 and a beta of 1.14. The firm has a 50 day moving average price of $21.07 and a 200 day moving average price of $21.49. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.31 and a current ratio of 1.31. Healthpeak Properties, Inc. has a 52-week low of $16.01 and a 52-week high of $23.26.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). The firm had revenue of $700.40 million for the quarter, compared to analyst estimates of $682.51 million. Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The firm’s revenue for the quarter was up 25.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.45 EPS. Analysts expect that Healthpeak Properties, Inc. will post 1.8 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.00%. The ex-dividend date was Monday, November 4th. Healthpeak Properties’s dividend payout ratio is currently 255.32%.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. Evercore ISI raised their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, September 16th. Royal Bank of Canada raised their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Wells Fargo & Company lowered their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price objective for the company from $20.00 to $28.00 in a research report on Monday, October 21st. Finally, Mizuho lowered their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Moderate Buy” and a consensus target price of $24.08.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.